Chronic losartan administration reduces mortality and preserves cardiac but not skeletal muscle function in dystrophic mice.
Duchenne muscular dystrophy (DMD) is a degenerative disorder affecting skeletal and cardiac muscle for which there is no effective therapy. Angiotension receptor blockade (ARB) has excellent therapeutic potential in DMD based on recent data demonstrating attenuation of skeletal muscle disease progre...
Main Authors: | Lawrence T Bish, Mark Yarchoan, Meg M Sleeper, Jeffrey A Gazzara, Kevin J Morine, Pedro Acosta, Elisabeth R Barton, H Lee Sweeney |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3120761?pdf=render |
Similar Items
-
Systemic myostatin inhibition via liver-targeted gene transfer in normal and dystrophic mice.
by: Kevin J Morine, et al.
Published: (2010-02-01) -
Myostatin is upregulated following stress in an Erk-dependent manner and negatively regulates cardiomyocyte growth in culture and in a mouse model.
by: Lawrence T Bish, et al.
Published: (2010-04-01) -
Rescue of dystrophic skeletal muscle by PGC-1α involves a fast to slow fiber type shift in the mdx mouse.
by: Joshua T Selsby, et al.
Published: (2012-01-01) -
Mechanical Properties of Maturing Dystrophic Skeletal Muscle
by: Wolff, Andrew
Published: (2014) -
Rhabdomyolysis with cardiac dystrophic calcification
by: Biplab Das, et al.
Published: (2016-01-01)